CD8A and melanoma: For instance, scientists at The Wistar Institute have successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models using synthetic DNA technology.193 CpG is a well-known and commonly used immunotherapeutic and vaccine adjuvant.